Danaher Corporation (NYSE:DHR) Shares Purchased by Value Partners Investments Inc.

Value Partners Investments Inc. increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 86.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,734 shares of the conglomerate’s stock after acquiring an additional 1,269 shares during the quarter. Value Partners Investments Inc.’s holdings in Danaher were worth $561,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. GHP Investment Advisors Inc. raised its stake in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 99 shares during the period. Heck Capital Advisors LLC acquired a new stake in Danaher during the fourth quarter worth about $27,000. Rialto Wealth Management LLC acquired a new stake in Danaher during the fourth quarter worth about $34,000. Hurley Capital LLC acquired a new stake in Danaher during the fourth quarter worth about $34,000. Finally, Dunhill Financial LLC raised its stake in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 67 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 1.7%

DHR stock opened at $200.85 on Thursday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $281.70. The firm has a market cap of $143.74 billion, a PE ratio of 39.00, a P/E/G ratio of 2.77 and a beta of 0.77. The firm has a 50 day simple moving average of $194.31 and a 200 day simple moving average of $209.00. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The business had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Equities research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.64%. Danaher’s dividend payout ratio is presently 24.85%.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Monday, June 9th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. JPMorgan Chase & Co. decreased their target price on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a research report on Tuesday, April 22nd. Bank of America decreased their target price on shares of Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Finally, Barclays upped their target price on shares of Danaher from $215.00 to $225.00 and gave the stock an “overweight” rating in a research report on Tuesday. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $248.61.

Insider Activity at Danaher

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the company’s stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the sale, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares of the company’s stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.